Skip to main content
Axmed

Our Story

Inaworldwherethegeographyofone'sbirthplaceoftendictatesthequalityofhealthcareonecanaccess,andfragmentedsystemskeepmedicinesfromreachingpatients,Axmedwasfoundedtochangethisreality.

We believe access to medicines and health products is a universal right, not a privilege. That conviction drives everything we do.

We're not just building better technology. We're building a fundamentally different kind of company.

As a social impact venture, transparency isn't a feature we offer. It's the foundation of everything we build. We show buyers exactly what they're paying for. No hidden fees. No unclear margins. Just honest pricing that puts more resources back into healthcare where they belong.

Since 2024, we have been working to transform healthcare access in low- and middle-income countries. Our focus is simple: enabling healthcare procurers to secure affordable, quality medicines and health products efficiently and reliably. Our technology makes this possible, but it's our commitment to doing business differently that makes all the difference.

This isn't just about procurement. It's about enabling healthcare systems to maximize their resources and improve outcomes for the people they serve.

Our Journey

From Vision to Scalable Impact

Our Solutions

Solutions That Transform Health Procurement

Axmed Marketplace is a dynamic Business-to-Business (B2B) platform connecting healthcare procurers with trusted pharmaceutical suppliers. By aggregating demand and applying smart technology, we lower procurement costs and deliver efficient logistics supporting healthcare systems to do more with less.

Explore Axmed Marketplace
Marketplace
Our Impact

Since our launch, we have enabled procurers across LMICs to unlock faster, more reliable access to medicines and health products while saving vital time and resources.

By supporting demand aggregation and streamlining procurement and supply chains, we're helping healthcare systems in LMICs do more with less.

4.2M

Patients reached

>35%
Patients reached
35% average cost savings on medicines and health products in 2025